AI assistant
Moderna, Inc. — Director's Dealing 2019
Dec 9, 2019
30610_dirs_2019-12-09_88ed2975-0793-43bd-9818-9f75090d09ce.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2019-12-06
Reporting Person: Kim Lorence H. (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-12-06 | Common Stock | M | 229357 | $20.64 | Acquired | 1371684 | Direct |
| 2019-12-06 | Common Stock | M | 229358 | $20.64 | Acquired | 1601042 | Direct |
| 2019-12-06 | Common Stock | S | 89698 | $19.34 | Disposed | 1511344 | Direct |
| 2019-12-06 | Common Stock | S | 147528 | $20.39 | Disposed | 1363816 | Direct |
| 2019-12-06 | Common Stock | S | 1306 | $20.93 | Disposed | 1362510 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-12-06 | Restricted Stock Units | $0 | M | 229357 | Disposed | Common Stock (229357) | Direct | |
| 2019-12-06 | Restricted Stock Units | $0 | M | 229358 | Disposed | Common Stock (229358) | Direct |
Footnotes
F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 12/28/2018, and amended on September 17, 2019. The sale was made to generate proceeds to cover the tax liability incident to the delivery of restricted stock units.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.86 to $19.85. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.87 to $20.86. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.92 to $20.97. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F5: These Restricted Stock Units are fully vested and settled in accordance with their terms.